Form 4: Director Acquires ESTA Shares in Lieu of Cash Retainer

Establishment Labs Holdings Director Nicholas Sheridan acquired 440 common shares at $56.78 each, opting for equity instead of a cash retainer.

Summary

• Nicholas Sheridan, a Director of Establishment Labs Holdings Inc., acquired 440 common shares.
• The shares were acquired on March 31, 2026, at a price of $56.78 per share.
• This acquisition was a result of an election to receive common shares instead of a quarterly cash retainer, as per the Issuer's Outside Director Compensation Policy.
• The shares were issued under the Issuer's 2018 Equity Incentive Plan.
• Following this transaction, Mr. Sheridan directly beneficially owns 1,077,315 common shares and indirectly owns 19,090 common shares through his spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating a director's continued confidence in the company by choosing equity over cash, which aligns their financial interests with long-term shareholder value.

Positives

• A director is increasing their direct equity stake in the company, aligning their interests with shareholders.
• The company's compensation policy allows directors to elect equity over cash, potentially conserving cash flow.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that director equity compensation is a common practice in the medical device and healthcare industry, aligning leadership incentives with long-term company performance and shareholder value. This specific transaction reflects a director's choice to deepen their personal investment in Establishment Labs, a company known for its medical aesthetics products.

Comparison to Industry Standards

• Director compensation policies allowing equity election are standard across many publicly traded companies, including peers in the medical technology sector like InMode Ltd. (INMD) or Align Technology, Inc. (ALGN), where executive and director compensation often includes a significant equity component to foster long-term alignment.
• The acquisition of shares in lieu of cash retainer is a common mechanism for directors to increase their stake, similar to practices seen at companies such as Johnson & Johnson (JNJ) or Medtronic plc (MDT) for their non-executive directors.

Corporate Governance

Stakeholder Impact

• Shareholders: Potentially positive, as increased insider ownership can signal confidence and better alignment of interests.
• Employees: Indirectly positive, as a stable and confident board can contribute to overall company stability.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction where a director opted for equity compensation. While it signals confidence, it is not a significant enough event on its own to warrant a change in investment recommendation. Investors should consider broader company fundamentals and market conditions.

Keywords

Establishment Labs Holdings, ESTA, Nicholas Sheridan, Director Compensation, Equity Incentive Plan, Insider Trading, Share Acquisition, Form 4, Beneficial Ownership